• OPEN AN ACCOUNT
Indian Indices
Sensex
82,496.41 464.60
( 0.57%)
Global Indices
Nasdaq
50,205.66 -574.76
(-1.13%)
Dow Jones
7,342.05 -19.48
(-0.26%)
Hang Seng
59,089.01 228.58
(0.39%)
Nikkei 225
10,545.68 -144.19
(-1.35%)
Forex
USD-INR
93.54 -0.42
(-0.44%)
EUR-INR
102.90 -0.55
(-0.53%)
GBP-INR
123.45 -0.54
(-0.44%)
JPY-INR
0.59 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Titan Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524717
INE150C01029
36.69382
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
60.64
2135.91
EPS(TTM)
Face Value()
Div & Yield %
6.82
2
0.1
 

Cravatex consolidated net profit rises 11.11% in the March 2026 quarter
May 16,2026
Net profit of Cravatex rose 11.11% to Rs 1.60 crore in the quarter ended March 2026 as against Rs 1.44 crore during the previous quarter ended March 2025. Sales declined 34.72% to Rs 39.51 crore in the quarter ended March 2026 as against Rs 60.52 crore during the previous quarter ended March 2025.

For the full year,net profit rose 40.79% to Rs 6.80 crore in the year ended March 2026 as against Rs 4.83 crore during the previous year ended March 2025. Sales declined 13.17% to Rs 150.87 crore in the year ended March 2026 as against Rs 173.76 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales39.5160.52 -35 150.87173.76 -13
OPM %-1.520.84 --4.23-0.98 -
PBDT2.622.51 4 10.087.85 28
PBT2.242.11 6 8.586.37 35
NP1.601.44 11 6.804.83 41